1998
DOI: 10.1006/phrs.1998.0324
|View full text |Cite
|
Sign up to set email alerts
|

Interaction Policosanol–warfarin on Bleeding Time and Thrombosis in Rats

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
5
0

Year Published

2000
2000
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 9 publications
(5 citation statements)
references
References 0 publications
0
5
0
Order By: Relevance
“…However, in contrast to the studies that have demonstrated benefit of policosanol in animals and humans with or without hypercholesterolemia, there are just as many studies that have demonstrated no effect on blood cholesterol [2,8,9,20 -24], coagulation [13,19,25] or antioxidant activity [11]. The majority of research reported in the literature has been conducted in Cuban laboratories relating to one specific policosanol product from sugar cane (SCP).…”
Section: Introductionmentioning
confidence: 91%
“…However, in contrast to the studies that have demonstrated benefit of policosanol in animals and humans with or without hypercholesterolemia, there are just as many studies that have demonstrated no effect on blood cholesterol [2,8,9,20 -24], coagulation [13,19,25] or antioxidant activity [11]. The majority of research reported in the literature has been conducted in Cuban laboratories relating to one specific policosanol product from sugar cane (SCP).…”
Section: Introductionmentioning
confidence: 91%
“…18,19 On the other hand, the antiplatelet and antithrombotic effects of policosanol have been associated with a reduction of serum thromboxane A 2 levels. 20,21 Negative results on the bone marrow micronucleus assays in rats and mice with oral and intraperitoneal administration of policosanol have been reported. Similar results showed the sister chromatic exchange and micronucleus in in vitro human lymphocytes.…”
Section: Resultsmentioning
confidence: 97%
“…Studies in animals and humans have shown that policosanol has pleiotropic properties that offer additional benefits in preventing atherosclerosis and complications, such as the inhibition of platelet aggregation [37][38][39][40][41][42][43][44][45] and lipid peroxidation. 24,46 There is some concern about the use of antiplatelet agents for primary CHD prevention.…”
Section: Discussionmentioning
confidence: 99%
“…47 In this study, the treatment groups were sufficiently similar in terms of all variables (ie, demographic, efficacy, and tolerability variables, including concomitant drug use), so that the effects described were considered drug related. Animal studies have shown that among concomitant drug therapies, policosanol exhibits interactions only with aspirin 38,42 and beta-blockers. 48 Thus, policosanol enhances the antiplatelet and antithrombotic effects of aspirin while increasing the antihypertensive effects of beta-blockers, without modifying the decrease in heart rate induced by such drugs.…”
Section: Discussionmentioning
confidence: 99%